Category Archives: Gadolinium
Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk
Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...
Research Suggest Fracking Chemicals Can Pollute Aquifers
A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.
Smokers More Vulnerable to Joint Replacement Failures
People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.
Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System
Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...
Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR
Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.
Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...
Federal DePuy ASR Hip Implant Trials Likely to Start This Year
It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...
FDA Gives 7 Companies Go Ahead To Market Generic Plavix
The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...
National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...
Omniscan NSF Lawsuit Settled
What would have been the first < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan lawsuit to go to a jury trial was settled at the last minute. The terms of the settlement are confidential, according to a report on ProPublica. Omniscan is gadolinium contrast dye that … Continue reading
First Omniscan Jury Trial Starts Today
The first jury trial involving General Electric’s < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye is scheduled to begin today. The plaintiff in the lawsuit, an elderly Minnesota woman, claims she developed nephrogenic systemic fibrosis (NSF) after being injected with Omniscan as part … Continue reading
Fewer Kidney Patients Received Gadolinium Agents Following 2006 NSF Alert
Fewer kidney patients have received < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dyes during MR studies since the US Food & Drug Administration (FDA) first issued warnings about their association with nephrogenic systemic fibrosis (NSF) in 2006. NSF is a condition involving the formation … Continue reading
FDA Strengthens Warnings on Gadolinium MRI Dyes
Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA for use with … Continue reading
Dutch Regulators Fault GE for Failing to Report Omniscan NSF Case
The Danish Medicines Agency has charged that GE Healthcare violated Dutch law when it failed to promptly and completely inform regulators about a patient who died after developing nephrogenic systemic fibrosis (NSF) following exposure to < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan contrast dye. According … Continue reading
GE Healthcare Advised to Restrict Omniscan in 2006
GE Healthcare’s own experts recommended in May 2006 that it proactively restrict the use of < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan, a gadolinium contrast dye, after it was linked to nephrogenic systemic fibrosis (NSF). According to a ProPublica investigation, rather than take that advice, … Continue reading
GE Drops Omniscan Libel Suit
GE Healthcare has dropped a libel suit it filed in the United Kingdom (UK) against a Danish researcher who had who warned its < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye was associated with nephrogenic systemic fibrosis (NSF) in 2007. When GE Healthcare sued … Continue reading
GE Using UK Libel Laws to Shield Omniscan from Criticism, Doctor Claims
General Electric has been accused of trying to stifle criticism of its < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye by a Danish radiologist who warned it was associated with nephrogenic systemic fibrosis (NSF) in 2007. According to an article in The Guardian, … Continue reading
FDA Should Tighten Restrictions on Omniscan, OptiMark, Panel Says
A panel of medical experts reviewing gadolinium contrast dyes recommended last week that the labeling for General Electric’s Omniscan and Covidien’s OptiMark should have stronger warnings regarding their risk of < "http://www.yourlawyer.com/topics/overview/nsf">nephrogenic systemic fibrosis (NSF). According to an article on … Continue reading
First NSF Lawsuit to Go to Trial in California
One of the first trials involving a < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye – Magnevist – and nephrogenic systemic fibrosis (NSF) is set to begin in January. According to a report on Law.com, the outcome of the Magnevist trial could be a … Continue reading
